Navigation Links
Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients
Date:11/29/2009

CHICAGO, Nov. 29 /PRNewswire/ -- Royal Philips Electronics ( PHG, AEX: PHI) today announced its response to an industry need by showing its portfolio of products designed to manage dose radiation at this year's 95th annual meeting of the Radiological Society of North America (RSNA) in Chicago. New this year from Philips are several advancements and upgrades focused on redefining imaging, managing dose radiation and streamlining workflow to expand upon clinical capabilities. Philips will also showcase the company's financing solutions for customers exploring radiology investments.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091129/NY17600LOGO )

Advancements in medical imaging are continuously opening new doors in early diagnosis and disease management. Despite the progress of this technology, both the radiology and patient communities have concerns regarding the potential risks of radiation dose. As healthcare guidelines continue to shift and more intense focus is directed to dose radiation risk and reduction, it is increasingly important radiologists have access to imaging systems that may limit exposure while upholding image quality and ease of use.

"Hospitals are under intense pressure to deliver high-quality care while lowering costs and exceeding standards for patient safety," said Gene Saragnese, CEO, Imaging Systems, Philips Healthcare. "Philips is dedicated to supporting our customers with systems that drive value and technologies that help enable a reduction of radiation dose to patients and hospital staff, while maintaining exceptional image quality to aid in the diagnosis and treatment of patients."

New solutions to redefine imaging and manage dose for patients and clinicians, alike

iDose for Philips CT

Philips is unveiling a new X-ray dose reduction technique, iDose. The newest addition to Philips' DoseWise suite of radiation management tools, iDose focuses on lowering X-ray dose while maintaining high image quality and fast reconstruction times. The iDose reconstruction technique, RapidView IR console, enables 20 times faster reconstruction than current hardware and lowers X-ray dose up to 80 percent while maintaining diagnostic image quality. As an ongoing commitment to streamlining workflow for radiologists, iDose was designed to provide the same look and feel of the original, higher-dose radiation images, so there's no additional training needed. iDose is available for new and installed base Brilliance iCT and 64-channel scanners with expected delivery in the second half of 2010.

DoseAware

For interventional radiologists, Philips will introduce DoseAware, the latest addition to Philips' DoseWise portfolio of solutions to help track X-ray exposure of patients and staff. DoseAware delivers real-time visualization, display and tracking of clinical staff X-ray dose to help healthcare professionals performing potentially lengthy interventional procedures manage their radiation exposure on the spot.

EasyDiagnost Eleva

A single fluoroscopy room is not cost-effective in today's environment with a shift of exams to other modalities. The combination of Philips' high-end digital vertical stand (or digital in-table detector) and the EasyDiagnost Eleva with ceiling suspension manages both high-quality digital radiography as well as fluoroscopy (DRF) applications, enabling users to perform gastro-intestinal work, as well as chest and skeletal exams, in just one room.

In addition, the DRF design consists of various single features to help enable lower X-ray doses to be delivered, including pediatric fluoroscopy settings, Grid Controlled Fluoroscopy and dose measurement. This is especially relevant in the pediatric setting. The Eleva is easy to operate, fast and offers the ability to customize protocols and techniques for individual physician preferences. Based on open standards, the EasyDiagnost Eleva can seamlessly integrate into any hospital network.

GEMINI TF PET/CT

Showcasing Philips' newest innovation in oncology care, the Philips GEMINI TF PET/CT streamlines the processes involved in staging, planning, therapy and follow-up in oncology care. With Generation 3 Time-of-Flight technology, the GEMINI TF system is the company's fastest ever PET scanner, capturing data in less than 500 picoseconds, without compromising image quality or attention to dose radiation efficiency.

Philips GEMINI TF is seeing increased traction for oncology diagnosis and follow-up. The U.S. Centers for Medicare and Medicaid Services (CMS) final decision expands coverage for Medicare patients for 11 cancer types and adds new coverage for initial treatment in seven other cancer indications. FDG-PET exams, such as those performed on the GEMINI TF, can be performed as part of the initial treatment strategy and to further guide subsequent treatment strategies. Philips GEMINI TF family will now play an even larger role in women's care due to the recent CMS decision to expand Medicare coverage for the reimbursement of exams for the initial staging of patients with biopsy-proven cervical cancer.

BrightView XCT SPECT/CT

Philips is showcasing new clinical images from the BrightView XCT. BrightView XCT using Astonish image reconstruction technology provides 50 percent better spatial resolution in cardiac SPECT studies compared to SPECT studies using filtered back projection. BrightView XCT helps enable low patient X-ray dose levels, high-resolution localization and high-quality attenuation correction with the potential for fewer artifacts and shorter exam times.

Additionally, Philips will highlight new clinical evidence that Philips' Astonish algorithms for nuclear cardiology help clinicians improve their diagnostic accuracy and increase their diagnostic confidence.

Allura Xper FD20 Release 7

For new and existing customers, the new release of the Allura Xper FD20 combines a full range of advanced interventional tools and seamless multi-modality cath lab integration. It also offers a balance between superb image quality and low X-ray dose during lengthy procedures. The system is upgradable, offering access to the latest clinical and service innovations as part of the lifetime Philips commitment.

Following the upgrade, the Allura Xper system will have advanced tools to support image-guided procedures. The MR/CT Roadmap feature allows clinicians to synchronize live fluoroscopy with previously Acquired MRA/CTA datasets to help reduce contrast media use and X-ray dose compared to standard 2D or 3D navigation.

Partnering for your success

Philips Medical Capital

Philips Medical Capital (PMC) provides financing tailored for the healthcare community. In today's weakened credit markets where borrowing money continues to be difficult, PMC stands apart, as a strong and stable finance company with money to lend. For healthcare providers concerned about careful cash flow management, expense monitoring or reducing financial leverage, PMC can help. Financing solutions are designed to address these and other pressing business concerns so providers can acquire the technology they need.

PMC is a joint venture between Philips Healthcare and De Lage Landen, a division of Dutch-owned, AAA-rated Rabobank. Rabobank has ranked in the top ten of the 'world's safest banks' survey by Global Finance for the past ten consecutive years.

Please find additional information on new products showcased at RSNA by visiting the Philips booth, #7725, located at McCormick Place, North Building, Hall B or visit http://www.philips.com/media.

.About Royal Philips Electronics

Royal Philips Electronics of the Netherlands ( PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs more than 118,000 employees in more than 60 countries worldwide. With sales of $38 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

SOURCE Philips Healthcare


'/>"/>
SOURCE Philips Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Philips Helps Hospitals Strike Balance Between Innovation and Value
2. Philips SmartArc Solution Helps Moffitt Cancer Center Reduce Radiation Treatment Time
3. Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
4. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
5. Endologix Responds to Alleged Patent Infringement
6. EPSScentral Responds to Pandemic Alert
7. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
8. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
9. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- Mederi Therapeutics Inc . hat die behördliche Zulassung durch die ... Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the ... at Wuhan Union Hospital ...
(Date:12/8/2016)... , December 8, 2016 According to ... Injection Pens Market is expected to be worth US$9.7 ... bn in 2015. Between the forecast years of 2016 and ... CAGR of 7.9%. The leading players operating in the global ... and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A. Transparency ...
(Date:12/8/2016)...  Avelas Biosciences, Inc., a clinical stage oncology-focused ... diagnosis through treatment, today presented clinical trial data ... in breast cancer patients utilizing investigational drug product ... Jonathan Unkart , M.D., resident physician at ... delivered the presentation titled "Intraoperative tumor detection using ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and the Affordable Care Act. Dr. Botelho advocates for the mass media launching ... movement gives people ongoing opportunities to share their unfortunate experiences; such a movement ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial planning services from offices headquartered in Little Rock, has initiated a charity ... According to the National Foundation to End Senior Hunger, Arkansas ranks first in ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coppin Insurance Agency, an insurance ... in and around the Cape Coral area, is embarking on a charity drive with ... Southwest Florida. , The Harry Chapin Food Bank of Southwest Florida works to provide ...
Breaking Medicine News(10 mins):